{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:47Z","timestamp":1787004827718,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670176"],"award-info":[{"award-number":["81670176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830007"],"award-info":[{"award-number":["81830007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070204"],"award-info":[{"award-number":["82070204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130004"],"award-info":[{"award-number":["82130004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Municipal Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR1032B"],"award-info":[{"award-number":["SHDC2020CR1032B"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502600"],"award-info":[{"award-number":["2022YFC2502600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1053\/j.seminhematol.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T02:11:48Z","timestamp":1690337508000},"page":"173-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Circulating tumor DNA in NK\/T and peripheral T cell lymphoma"],"prefix":"10.1053","volume":"60","author":[{"given":"Yu-Jia","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.seminhematol.2023.07.003_bib0001","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(09)70265-7","article-title":"Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Kwong","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.07.003_bib0002","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.07.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.07.003_bib0004","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.03614-14","article-title":"Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection","volume":"89","author":"Palser","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/cas.13954","article-title":"Epstein-Barr virus strain variation and cancer","volume":"110","author":"Kanda","year":"2019","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.07.003_bib0006","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/cancers13061414","article-title":"EBV and the pathogenesis of NK\/T cell lymphoma","volume":"13","author":"Montes-Mojarro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminhematol.2023.07.003_bib0007","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.2147\/OTT.S155930","article-title":"Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer\/T-cell lymphoma in vivo and in vitro","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1053\/j.seminhematol.2023.07.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103614","article-title":"SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential","volume":"72","author":"Xiong","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","article-title":"How we treat NK\/T-cell lymphomas","volume":"15","author":"Tse","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.07.003_bib0011","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.07.003_bib0012","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.07.003_bib0013","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/leu.2015.44","article-title":"Prognostic nomogram for overall survival in previously untreated patients with extranodal NK\/T-cell lymphoma, nasal-type: a multicenter study","volume":"29","author":"Yang","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0014","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41375-020-0791-3","article-title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.07.003_bib0015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"25","key":"10.1053\/j.seminhematol.2023.07.003_bib0016","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.07.003_bib0017","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.07.003_bib0019","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.07.003_bib0020","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.07.003_bib0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1600-065X.2003.00008.x","article-title":"The PI-3 kinase\/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3","volume":"192","author":"Kane","year":"2003","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.07.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0023","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.07.003_bib0024","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021015019","article-title":"DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS","volume":"140","author":"Herek","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.07.003_bib0025","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba","year":"2020","journal-title":"Leukemia"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.07.003_bib0026","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1084\/jem.20190678","article-title":"Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells","volume":"216","author":"Rodriguez","year":"2019","journal-title":"J Exp Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.07.003_bib0027","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.annonc.2021.12.002","article-title":"The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma","volume":"33","author":"Horwitz","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-020-00889-z","article-title":"Biomarker-driven management strategies for peripheral T cell lymphoma","volume":"13","author":"Mulvey","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.07.003_bib0029","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.07.003_bib0030","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.07.003_bib0031","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","article-title":"Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan","volume":"119","author":"Tokunaga","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.07.003_bib0032","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.2020010387","article-title":"Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project","volume":"138","author":"Advani","year":"2021","journal-title":"Blood"},{"issue":"18","key":"10.1053\/j.seminhematol.2023.07.003_bib0033","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of Cell-free dna analysis to cancer treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.07.003_bib0034","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41416-020-01047-5","article-title":"Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond","volume":"124","author":"Keller","year":"2021","journal-title":"Br J Cancer"},{"issue":"224","key":"10.1053\/j.seminhematol.2023.07.003_bib0035","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.07.003_bib0036","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood.2021012852","article-title":"Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma","volume":"139","author":"Meriranta","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0037","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2023.07.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.02605","article-title":"Circulating tumor DNA in the blood: A new frontier in primary CNS lymphoma?","author":"Grommes","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6151","key":"10.1053\/j.seminhematol.2023.07.003_bib0039","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1235226","article-title":"Cancer. Circulating tumor cells","volume":"341","author":"Plaks","year":"2013","journal-title":"Science"},{"issue":"34","key":"10.1053\/j.seminhematol.2023.07.003_bib0040","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1200\/JCO.2017.74.5281","article-title":"Minimal residual disease assessment in lymphoma: methods and applications","volume":"35","author":"Herrera","year":"2017","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1053\/j.seminhematol.2023.07.003_bib0041","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.07.003_bib0042","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","article-title":"Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis","volume":"2","author":"Kim","year":"2015","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.07.003_bib0043","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/leu.2013.212","article-title":"Quantification of circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance","volume":"28","author":"Kwong","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.07.003_bib0044","article-title":"Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer\/T-cell lymphoma: a randomized phase III study","volume":"4","author":"Zhong","year":"2023","journal-title":"Innovation (Camb)"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.07.003_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7150\/jca.27615","article-title":"Mutation profiling of malignant lymphoma by next-generation sequencing of circulating cell-free DNA","volume":"10","author":"Sun","year":"2019","journal-title":"J Cancer"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.07.003_bib0046","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ejh.13736","article-title":"Mutation profiling of circulating tumor DNA identifies distinct mutation patterns in non-Hodgkin lymphoma","volume":"108","author":"Fu","year":"2022","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.07.003_bib0047","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00277-020-04008-3","article-title":"Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas","volume":"99","author":"Hur","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2023.07.003_bib0048","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40364-020-00205-4","article-title":"Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK\/T-cell lymphoma","volume":"8","author":"Li","year":"2020","journal-title":"Biomark Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0049","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1097\/HS9.0000000000000822","article-title":"The novel prognostic index model of combining circulating tumor DNA and PINK-E predicts the clinical outcomes for newly diagnosed extranodal NK\/T-cell lymphoma","volume":"7","author":"Huang","year":"2023","journal-title":"Hemasphere"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.07.003_bib0050","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/bloodadvances.2020001637","article-title":"Liquid biopsy in extranodal NK\/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring","volume":"5","author":"Qi","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.07.003_bib0051","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1080\/10428194.2019.1573998","article-title":"Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes","volume":"60","author":"Shin","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.07.003_bib0052","article-title":"Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer\/T cell lymphoma","volume":"4","author":"Tian","year":"2023","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.07.003_bib0053","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcv.2007.08.013","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases","volume":"40","author":"Suwiwat","year":"2007","journal-title":"J Clin Virol"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.07.003_bib0054","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/ijc.30566","article-title":"Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas","volume":"140","author":"Haverkos","year":"2017","journal-title":"Int J Cancer"},{"issue":"54","key":"10.1053\/j.seminhematol.2023.07.003_bib0055","doi-asserted-by":"crossref","first-page":"92312","DOI":"10.18632\/oncotarget.21251","article-title":"Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.07.003_bib0056","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000516588","article-title":"Clinical significance of plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas","volume":"145","author":"Zhao","year":"2022","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.003_bib0057","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4143\/crt.2022.017","article-title":"Circulating tumor DNA-based genotyping and monitoring for predicting disease relapses of patients with peripheral T-cell lymphomas","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res Treat"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.07.003_bib0058","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/bloodadvances.2019001075","article-title":"Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma","volume":"4","author":"Ottolini","year":"2020","journal-title":"Blood Adv"},{"issue":"20","key":"10.1053\/j.seminhematol.2023.07.003_bib0059","first-page":"4198","article-title":"Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL","volume":"5","author":"Miljkovic","year":"2021","journal-title":"Blood Adv"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:42Z","timestamp":1758522522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0037196323000574"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.07.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor DNA in NK\/T and peripheral T cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}